skip to main content

S. 1785: Fair AMP Act

The text of the bill below is as of Jun 11, 2019 (Introduced).


II

116th CONGRESS

1st Session

S. 1785

IN THE SENATE OF THE UNITED STATES

June 11, 2019

(for herself, Mr. Cassidy, Ms. Stabenow, Mr. Cornyn, Mr. Cardin, and Mr. Young) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.

1.

Short title

This Act may be cited as the Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act.

2.

Excluding authorized generic drugs from calculation of average manufacturer price under the Medicaid drug rebate program; excluding manufacturers from definition of wholesaler

(a)

In general

Subparagraph (C) of section 1927(k)(1) of the Social Security Act (42 U.S.C. 1396r–8(k)(1)) is amended—

(1)

in the subparagraph heading, by striking Inclusion and inserting Exclusion;

(2)

by striking a new drug application and inserting the manufacturer's new drug application; and

(3)

by striking inclusive and inserting exclusive.

(b)

Excluding manufacturers from definition of wholesaler

Section 1927(k)(11) of the Social Security Act (42 U.S.C. 1396r–8(k)(11)) is amended—

(1)

by striking manufacturers,; and

(2)

by striking manufacturer's and.

(c)

Effective date

The amendments made by this section shall take effect on the first day of the first fiscal quarter that begins after the date of enactment of this Act.